Skip to main content
SpringerLink
Log in

7 Vrouwen en hart- en vaatziekten: de overgang

  • Chapter
Cardiologie

Part of the book series: Praktische huisartsgeneeskunde ((PHG))

Samenvatting

Omdat vrouwen relatief beschermd zijn door hun hormonale status in de vruchtbare levensfase treden cardiovasculaire ziekten (CVZ) bij hen gemiddeld 7-10 jaar later op dan bij mannen. In de jaren na de menopauze wordt het cardiovasculaire risicoprofiel ongunstiger, waardoor vrouwen een inhaalslag maken. Terwijl mannen een hogere sterfte hebben aan myocardinfarcten, overlijden jaarlijks meer vrouwen aan hartfalen en CVA’s (Figuur 7.1). De afgelopen twee decennia is zowel het aantal myocardinfarcten als het aantal CVA’s bij vrouwen op middelbare leeftijd toegenomen. Door een minder gezonde leefstijl en toename in gewicht ontwikkelen veel vrouwen diabetes en hypertensie. Daarnaast zijn vooral jonge vrouwen meer gaan roken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Leesadvies

  • Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas 1999;33:259–69.

    Article  CAS  PubMed  Google Scholar 

  • Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9.

    Article  CAS  PubMed  Google Scholar 

  • Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, Kaaja R, Mikkola T, Palacios S, Preston R, Simon T, Stevenson J, Stramba-Badiale M. Management of cardiovascular risk in the perimenopausal woman: a consensus statement of European cardiologist and gynaecologists. Eur Heart J 2007;28:2028-40.

    Article  PubMed  Google Scholar 

  • Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. An age-old debate. Hypertension 2008;51:952-9.

    CAS  PubMed  Google Scholar 

  • De Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010;28:353-60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • DeVos M, Devroey P, Fauser BCJM. Primary ovarian insufficiency. Lancet 2010;376:911-21.

    Article  Google Scholar 

  • Drost JT, Maas AH, Eyck J van, Schouw YT van der. Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas 2010;67:321-6.

    Article  PubMed  Google Scholar 

  • Gast G-CM, Grobbee DE, Pop VJM, Keyzer JJ, Wijnands-van Gent CJM, Samsioe GN, Nilsson PM, Schouw YT van der. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-8.

    Article  CAS  PubMed  Google Scholar 

  • Gast G-CM, Pop VJ, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, Wijnands-van Gent CJ, Schouw YT van der. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 2011;18:146-51.

    Google Scholar 

  • Genders TSS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 2011;32:1316-30.

    Article  PubMed  Google Scholar 

  • Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory blood pressure. Menopause 2007;14:308-15.

    Article  PubMed  Google Scholar 

  • Gulati M, Cooper-DeHoff RM, McClure C, Johnson D, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. A report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women take Heart Project. Arch Intern Med 2009;169:843-50.

    Google Scholar 

  • Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E. Prevalence of angina in women versus men. A systematic review and meta-analysis of international variations across 31 countries. Circulation 2008;117:1526-36.

    Google Scholar 

  • Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-8.

    Article  PubMed Central  PubMed  Google Scholar 

  • Ikeda H, Inoue T, Uemura S, et al. Effects of candesartan for middle-aged and elderly women with hypertension and menopausal- like symptoms. Hypertens Res 2006;29:1007-12.

    Article  CAS  PubMed  Google Scholar 

  • Kip KE, Marroquin OC, Kelley DE, et al. Clinical importanc of obesity versus the metabolic syndrome in cardiovascular risk in womn. Circulation 2004;109:706-13.

    Article  PubMed  Google Scholar 

  • Kohli P, Gulati M. Exercise testing in women. Going back to the basics. Circulation 2010;122:2570-80.

    Google Scholar 

  • Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al. for the EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929-40.

    Article  PubMed  Google Scholar 

  • Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-8.

    Article  PubMed  Google Scholar 

  • Maas AHEM, Lagro-Janssen ALM. Handboek Gynaecardiologie: vrouwspecifieke cardiologie in de praktijk. Houten: Bohn Stafleu van Loghum, 2011.

    Book  Google Scholar 

  • Maas AHEM, Schouw YT van der, Grobbee DE, Graaf Y van der. ‘Rise and fall’ of hormone therapy in postmenopausal women with cardiovascular disease. Menopause 2004;11:228-35.

    Google Scholar 

  • Maas AHEM, Schouw YT van der, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, et al. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women. Eur Heart J 2011;32:1362-8.

    Article  PubMed  Google Scholar 

  • Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11.

    Article  CAS  PubMed  Google Scholar 

  • Shaw LJ, Bugiardini R, Bairey Merz CN. Women and ischemic heart disease. Evolving knowledge. J Am Coll Cardiol 2009;54:1561-75.

    Article  PubMed Central  PubMed  Google Scholar 

  • Szmuilowicz ED, Manson JE, Rossouw JE, Howard BV, Margolis KL, Greep NC, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011;18:603-10.

    Article  PubMed Central  PubMed  Google Scholar 

  • Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256-61.

    Article  PubMed Central  PubMed  Google Scholar 

  • Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Powell LH, Matthews KA. Hot flashes and carotid intima media thickness among midlife women. Menopause 2011;18:352-8.

    Article  PubMed Central  PubMed  Google Scholar 

  • Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. ArchIntern Med 2009;169:1762-66.

    Article  PubMed  Google Scholar 

  • Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33.

    Google Scholar 

Website

Download references

Author information

Authors and Affiliations

  1. afdeling Cardiologie, UMC St Radboud, Nijmegen

    Prof. dr. A.H.E.M. Maas (cardioloog)

  2. Universitaire Huisartsenpraktijk, Nijmegen

    Prof. dr. A.L.M. Lagro-Janssen (hoogleraar vrouwenstudies medische wetenschappen)

Authors
  1. Prof. dr. A.H.E.M. Maas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. dr. A.L.M. Lagro-Janssen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitair Medisch Centrum St Radboud, Nijmegen

    J.C. Bakx (huisarts te Doesburg, onderzoeker) (huisarts te Doesburg, onderzoeker)

  2. afdeling Cardiologie, Onze Lieve Vrouwe Gasthuis, Amsterdam

    F.W.A. Verheugt (cardioloog) (cardioloog)

  3. afdeling Cardiologie, Thoraxcentrum, Erasmus MC, Rotterdam

    J.W. Deckers (cardioloog/epidemioloog) (cardioloog/epidemioloog)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Bohn Stafleu van Loghum, onderdeel van Springer Media

About this chapter

Cite this chapter

Maas, A., Lagro-Janssen, A. (2013). 7 Vrouwen en hart- en vaatziekten: de overgang. In: Bakx, J., Verheugt, F., Deckers, J. (eds) Cardiologie. Praktische huisartsgeneeskunde. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9028-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-9028-1_7

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-9027-4

  • Online ISBN: 978-90-313-9028-1

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation